BiotechTube
Home/NuVision Biotherapies/Dr. Andrew Hopkinson
DA

Dr. Andrew Hopkinson

Founder and Chief Scientific Officer

NuVision Biotherapies

Therapeutic Areas

OphthalmologyRegenerative Medicine

NuVision Biotherapies Pipeline

DrugIndicationPhase
OmnigenOcular surface wound healing (e.g., corneal defects, ulcers, dry eye disease)Commercial
OmniLenzSurgery-free ocular care (therapeutic contact lens)Commercial

Leadership Team at NuVision Biotherapies

RT
Roger Teasdale
Chairman
NW
Noel Waters
Chief Operating Officer
TG
Tim Gray
Chief Financial Officer
View full NuVision Biotherapies profile